Navigation Links
Cost effective prostate cancer treatment underused in the UK
Date:4/21/2013

a research grant provided by Elekta.

Notes to editors
Judith Moore
Burson Marsteller
T: +44 (0) 20 7300 6275
M +44 (0)7 932 053 829
judith.moore@bm.com

About PANAXEA

PANAXEA is spin-off consultancy of the University of Twente that answers to the growing demand for accelerating safe, effective and cost-effective new medical technologies to the patient. As bringing biomedical products to the market is a lengthy and uncertain process, we offer health economic expertise to model cost-effectiveness and clinical impact, even at the earliest stages of biomedical product development. PANAXEA provides science-based business intelligence and competitive advantage to:

- Improve business plans and attract investors

- Support (pre-)clinical research strategies

- Develop market access strategies

- Prepare (global) reimbursement claims

- Guide decisions on implementation

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website:

SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
2. Downsizing and the Need for Increased Selling Effectiveness Fuel Delta Points Growth
3. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
4. Researchers reveal why some pain drugs become less effective over time
5. UK company to demonstrate their commercially effective graphene production process
6. The Italian Institute of Prophylaxis against Animal Diseases (IZS) to test effectiveness of BeesFree Inc.s Technology in Combating Colony Collapse Disorder
7. CSL Behring Data Shows 4-Factor Prothrombin Complex Concentrate Is As Effective and a More Rapid Treatment for Vitamin K Antagonist Reversal Than Current Standard of Care
8. AQUA® Technology Uses Extend Beyond Protein: Effective measurement of messenger RNA now demonstrated
9. Peers Underscored As An Effective Counseling Tool
10. Stem Cell Therapy Shown to be Effective in Treating Liver Cirrhosis
11. Protein that helps tumor blood vessels mature could make cancer drugs more effective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Intrinsic Imaging, an ... GAMP® 5 compliant imaging core lab, announced today ... II clinical trial to assess a new treatment ... trial, Intrinsic Imaging will provide comprehensive imaging core ... and charter development, site qualification, site training and ...
(Date:8/28/2014)... 28, 2014 “This kit has an improved ... from 0 to 150 ppb,” said Mark Tess, PhD, Mycotoxin ... benefit to plant owners and USDA-GIPSA inspection agencies that have ... Testing can take place in a matter of minutes with ... plant test the feed and grain before accepting it, but ...
(Date:8/28/2014)... 28, 2014 The ability for organizations ... that will allow individuals to perform at the highest ... for employers looking to compete in this post–recession era. ... this trend, as the sector increasingly focuses on the ... which will have real results on the organization's development ...
(Date:8/28/2014)... Aug. 28, 2014  Armetheon, Inc. ( www.armetheon.com ... mid- to late-stage cardiovascular drug candidates, today announced ... first round of financing. The Series A round ... Bioventures with participation from investors that included Atheneos ... Dr. Larry Hsu , the founder of ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3
... on DAVID enable researchers to quickly and effectively use this invaluable ... ... OpenHelix today announced the availability of a new tutorial ... "DAVID." DAVID is a free, web-based bioinformatics tool that ...
... innovative measurement techniques, researchers from the Georgia Institute ... and Technology (NIST) have directly measured the unusual ... form of carbon that has tantalized and puzzled ... in this week,s issue of Science ,* ...
... (TSX:ONC, NASDAQ: ONCY ) announced today that data from ... at the 2009 American Society of Clinical Oncology (ASCO) Annual ... 29-June 2, 2009. The abstracts are available on the ASCO ... poster presentations, - Dr. Monica ...
Cached Biology Technology:New Online Tutorial for DAVID 2Graphene yields secrets to its extraordinary properties 2Oncolytics Biotech(R) Inc.'s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference 2
(Date:8/28/2014)... Mayo Clinic researcher and his collaborators have developed an ... the process of re-engineering cells for biomedical investigation. CellNet ... methods to aid stem cell engineering. Details of CellNet ... in two back-to-back papers in the journal Cell ... of uses for all types of cell-based investigations and ...
(Date:8/28/2014)... 2014  Privacy Advocate and Senior Staff Attorney at ... joins the lineup of biometric and mobile commerce experts ... Executive Summit in Tampa, Florida ... speakers include Steven Rahman, Director, Technology and Strategy at Samsung, ... The theme of this year,s event is Mobility at ...
(Date:8/28/2014)... Philadelphia, PA, August 28, 2014 Dyslexia, the ... States, is a neurological reading disability that occurs ... written language don,t function normally. , The use ... how brain activity is disrupted in dyslexia. However, ... small number of brain regions, leaving a gap ...
Breaking Biology News(10 mins):New tool aids stem cell engineering for medical research 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2Dyslexic readers have disrupted network connections in the brain 2
... American babies are born deaf. The numbers increase markedly with ... States experiencing some form of hearing loss. But ... in-laws, may soon be over. A new, landmark study ... Aviv University has uncovered one of the root causes of ...
... has hit pay dirt for Case Western Reserve University ... The researchers have created a line of patented ... that can take on the shape and size of ... trays to rubber ducky molds to clam-shell packaging molds ...
... severe dementia in patients with Alzheimer,s disease. Until ... the neuronal devastation in post mortem animal models, ... German Center for Neurodegenerative Disease at Ludwig-Maximilians-Universitaet (LMU) ... successfully observed this demise of nerve cells by ...
Cached Biology News:Scaling the wall of deafness 2Scaling the wall of deafness 3Case Western Reserve University engineers hit pay dirt with clay mixture 2Case Western Reserve University engineers hit pay dirt with clay mixture 3Alzheimer cell death in Zebrafish: Demise of neurons observed live for the first time 2
... Mouse anti-Yersinia pestis F1 antigen, Monoclonal ... ELISA: Use at an ... an assay dependent dilution. WB: Use ... molecular weight: 18 kDa. Not tested ...
Anti-Phospho-JKK/SEK1/MKK4 pAb Description: 100 g rabbit polyclonal antibody. Reacts with human/mouse/rat. Tested in WB. Research Focus: signal transduction Storage: -20C Shipping Tem...
... A - Fixation medium Reagent B - ... for fixing cells in suspension with Reagent ... Reagent B. This procedure gives antibodies access ... scatter characteristics of the cells intact. Specific ...
... formulated for covering tissue sections and cell preparations immunohistochemically stained ... , ... Application: Vision Mount ... that require an aqueous mounting medium, or those that do ...
Biology Products: